Last updated: June 4, 2026
SYMBICORT suppliers: inhaler components, manufacturing network, and contract partners
Executive summary
SYMBICORT (budesonide/formoterol fumarate dihydrate) is supplied by AstraZeneca for the US market. The commercial supply chain is anchored by AstraZeneca’s global inhalation manufacturing network and filled-pack operations, with specialized suppliers for pressurized metered-dose inhaler (pMDI) or DPIs only where the dosage form uses externally sourced subcomponents (notably canisters, valves/actuators, and packaging components).
No complete, authoritative, component-level supplier roster for SYMBICORT at the same granularity as an audit-ready procurement map is available from the information provided.
Who manufactures SYMBICORT (AstraZeneca) and which plants supply US demand?
SYMBICORT is marketed in the US by AstraZeneca under NDA ownership for budesonide/formoterol combinations, with supply produced through AstraZeneca’s inhalation manufacturing network (AstraZeneca site footprint for inhalers varies by market and product strength).
For a procurement-grade answer (factory-by-factory, SKU-by-SKU), supplier identification must be derived from primary regulatory and manufacturing disclosures (for example, FDA labeling manufacturing statements, import records tied to the listed manufacturer of record, and EU/US registration dossiers). Those source documents are not included in the information provided.
Key supply-chain elements typically determined by regulator disclosures
- Drug substance manufacturer (budesonide, formoterol intermediate/formoterol base salts)
- Drug product manufacturer of record (spray-dried powder vs solution-based pMDI manufacture depending on presentation)
- Primary packaging manufacturer (inhaler device components)
- Secondary packaging and labeling partner (carton, inserts, and compliance labeling)
What suppliers provide SYMBICORT inhaler components (valves, canisters, actuator, packaging)?
SYMBICORT’s inhaler device supply depends on the dosage form used in each market presentation. For inhalation combination products, common external sourcing categories include:
- Container closure system subcomponents (for example, canisters and valves for pMDI presentations)
- Actuator/adapter parts (mouthpiece, metering components)
- Cartridge or blister packaging components (for multi-dose dry powder formats)
- Child-resistant packaging and patient instructions printed by contract printers
Without the specific SYMBICORT presentation in scope (strength and device type) and without primary labeling/manufacturing disclosures, a definitive supplier list cannot be produced from the information provided.
Which companies are the contract manufacturers for SYMBICORT (CMO/CDMO partners)?
A contract manufacturing relationship for SYMBICORT would normally be disclosed through:
- The “Manufactured for” and “Manufactured by” language on US FDA labeling for each product strength
- Importer of record and manufacturer-of-record on US customs data
- EU manufacturing authorizations and manufacturing site statements in SmPC/annexes
Those documents are not provided, so a credible CMO/CDMO supplier identification cannot be completed from the information provided.
What does the FDA label say about SYMBICORT manufacturer of record and plant sites?
The definitive source for “who supplies” in the regulatory sense is the FDA label section that identifies:
- Manufacturer of drug product (company and address)
- Packager and/or labeler (if different)
- Storage conditions and packaging format
The label text and product-specific NDC/manufacturer statements are not included in the information provided, so no authoritative supplier list can be returned.
Is SYMBICORT supplied as a finished inhaler by AstraZeneca or assembled from external inputs?
In most inhalation combination products, the drug product is produced and then assembled with device components under controlled configuration. In practice, two supply patterns are common:
- Vertical supply: AstraZeneca manufactures the drug product and assembles the inhaler device (internal or under internal procurement).
- Hybrid supply: AstraZeneca manufactures drug product and sources selected device subcomponents from qualified external vendors, then performs final assembly under GMP.
A pattern cannot be verified for SYMBICORT without the missing manufacturer and device composition disclosures in the information provided.
What is the Orange Book status of SYMBICORT that affects supplier qualification and device sourcing?
Orange Book listings identify approved drug products and patent estates but do not provide an inhaler-device supplier roster. They can, however, indicate the authorized product configuration and the marketed drug product(s) that drive which manufacturing sites are relevant.
Orange Book data for SYMBICORT is not included in the information provided, preventing a supplier-qualification linkage.
How do SYMBICORT generic or authorized generic entries affect supply sourcing for the reference product?
Generic entry typically affects demand and procurement leverage, but reference-product supplier maps are still set by AstraZeneca’s manufacturing authorization for the branded product. Without the specific competitive context and without manufacturer-of-record and device configuration for SYMBICORT presentations, the impact cannot be quantified from the information provided.
Key Takeaways
- SYMBICORT is supplied by AstraZeneca as the branded manufacturer of record in the US, using an inhalation manufacturing network that may include external sourcing for device subcomponents such as canisters/valves/actuators and packaging components.
- A complete, named supplier roster for SYMBICORT at component level (valve, actuator, canister, printing, labeling, fill-finish, and device assembly) cannot be produced from the information provided.
- The procurement-grade path to supplier identification requires product-specific FDA labeling/manufacturer-of-record statements tied to the exact SYMBICORT strength and inhaler presentation.
FAQs
- Who is the manufacturer of SYMBICORT in the US on the FDA label?
- What device components are typically outsourced for combination inhalers like SYMBICORT?
- How can you identify the contract manufacturer for SYMBICORT by NDC and label “Manufactured by” text?
- Do Orange Book patents list the device supplier for SYMBICORT?
- Where do you find the inhaler manufacturer-of-record for each SYMBICORT strength (UDI/NDC label, import records, EU dossier)?
References
(No sources were provided in the information provided.)
